Evaluation of the effect of probiotics in the treatment of jaundice

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220425054656N1

Enrollment

Registered

2022-11-04

Start date

2022-04-30

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal jaundice. Hyperbilirubinaemia without mention of jaundice, not elsewhere classified

Interventions

Intervention 1: Intervention group: recipient of probiotic drops along with phototherapy, daily recipient of 6 drops of probiotics from Rotfeld company. Intervention 2: Control group: Infants receivin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Semester infants with jaundice

Exclusion criteria

Exclusion criteria: Hospitalized infants with a diagnosis of jaundice who have sepsis 2 admitted with a diagnosis of jaundice who have respiratory distress Increased jaundice with the necessary amounts for blood transfusion Jaundice due to blood group incompatibility and RH Direct hyperbilirubinemia Infants with severe congenital anomalies

Design outcomes

Primary

Measure	Time frame
Neonatal jaundice. Timepoint: 0?24?48?72 hour. Method of measurement: Bilirubin detection kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasim khalili dizaji

Oroumia University of Medical Sciences

Nasimkhalilidizaji@gmail.com+98 44 3223 4897

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026